1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
CSF and blood biomarkers for Parkinson's disease
Parnetti, Lucilla ; Gaetani, Lorenzo ; Eusebi, Paolo ; Paciotti, Silvia ; Hansson, Oskar LU
; El-Agnaf, Omar
; Mollenhauer, Brit
; Blennow, Kaj
LU
and Calabresi, Paolo
(2019)
In The Lancet Neurology
18(6).
p.573-586
Mark
-
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
Sjödin, Simon ; Brinkmalm, Gunnar ; Öhrfelt, Annika ; Parnetti, Lucilla ; Paciotti, Silvia ; Hansson, Oskar LU
; Hardy, John
; Blennow, Kaj
LU
; Zetterberg, Henrik
LU
and Brinkmalm, Ann
(2019)
In Alzheimer's Research and Therapy
11(1).
Mark
-
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
Cicognola, Claudia ; Brinkmalm, Gunnar ; Wahlgren, Jessica ; Portelius, Erik ; Gobom, Johan ; Cullen, Nicholas C. ; Hansson, Oskar LU
; Parnetti, Lucilla
; Constantinescu, Radu
and Wildsmith, Kristin
, et al.
(2019)
In Acta Neuropathologica
137(2).
p.279-296
Mark
- 2018
-
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
Jansen, Willemijn J. ; Ossenkoppele, Rik LU ; Tijms, Betty M. ; Fagan, Anne M. ; Hansson, Oskar LU
; Klunk, William E.
; Van Der Flier, Wiesje M.
; Villemagne, Victor L.
; Frisoni, Giovanni B.
and Fleisher, Adam S.
, et al.
(2018)
In JAMA Psychiatry
75(1).
p.84-95
Mark
- 2017
- Cerebrospinal fluid in Alzheimer's : A precious tool
-
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease : protocol for a systematic review and individual participant data meta-analysis
Eusebi, Paolo ; Hansson, Oskar LU
; Paciotti, Silvia
; Orso, Massimiliano
; Chiasserini, Davide
; Calabresi, Paolo
; Blennow, Kaj
LU
and Parnetti, Lucilla
(2017)
In BMJ Open
7(11).
p.018177-018177
Mark
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
- Consensus guidelines for lumbar puncture in patients with neurological diseases
- Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
- 2016
-
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
Parnetti, Lucilla ; Cicognola, Claudia LU
; Eusebi, Paolo
and Chiasserini, Davide
(2016)
In Biomarkers in Medicine
10(1).
p.35-49
Mark